Doctor profile · Federal record
Dr. Tara Adhikari, MD
Rheumatology Physician (CMS: Rheumatology) · Blue Ash, OH
- NPI 1508068594
- Accepts Medicare
- 26 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
9403 Kenwood RD Ste C100
Blue Ash, OH 452426857
(513) 991-9990
fax (513) 991-9989
Credentials & registration
- NPI registered
- June 2007 — 19 yrs on file
- Profile last updated
- February 23, 2026
- Year of graduation
- 2000 — 26 yrs since
- Specialty taxonomy
- 207RR0500X — NUCC code
- State license (1)
- Missouri #2011035519
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1508068594. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
158,049
Distinct HCPCS
10
Medicare allowed
$1,980,855
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J0717 |
Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 118,800 | 44 | $5 | |
J0129 |
Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 23,425 | 39 | $42 | |
J1602 |
Injection, golimumab, 1 mg, for intravenous use | 10,035 | 16 | $13 | |
J0897 |
Injection, denosumab, 1 mg | 3,600 | 42 | $23 | |
96401 |
Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 641 | 80 | $67 | |
96413 |
Administration of chemotherapy into vein, 1 hour or less | 418 | 70 | $119 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 380 | 227 | $121 | |
99215 |
Established patient office or other outpatient visit, 40-54 minutes | 251 | 200 | $170 | |
J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 136 | 26 | $1 | |
J7030 |
Infusion, normal saline solution , 1000 cc | 83 | 42 | $3 |
In context: peer comparison
Among 1 peers in this city , average services per provider: 9,297. This provider delivers 17× the peer median.Open Payments
Industry payments received
All-time total
$557
Transactions
19
Manufacturers
9
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Axsome Therapeutics, Inc. | 1 | $119.97 | |
| UCB, Inc. | 5 | $89.70 | |
| Janssen Biotech, Inc. | 1 | $80.56 | |
| Amgen Inc. | 4 | $73.10 | |
| ABBVIE INC. | 3 | $64.72 | |
| Cardinal Health Inc | 1 | $42.85 | |
| PFIZER INC. | 2 | $40.17 | |
| Lilly USA, LLC | 1 | $31.22 | |
| AstraZeneca Pharmaceuticals LP | 1 | $14.40 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
2,308
Patients
732
Total drug cost
$1,332,378
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Prednisone | Generic | 479 | 197 | $4,611 |
| Hydroxychloroquine Sulfate | Generic | 477 | 147 | $42,356 |
| Methotrexate (Methotrexate Sodium) | Brand | 442 | 137 | $15,787 |
| Allopurinol | Generic | 166 | 52 | $2,810 |
| Leflunomide | Generic | 165 | 50 | $18,424 |
| Duloxetine Hcl | Generic | 84 | 32 | $2,851 |
| Folic Acid | Generic | 78 | 26 | $328 |
| Sulfasalazine | Generic | 67 | 23 | $2,289 |
| Enbrel Sureclick (Etanercept) | Brand | 63 | 0 | $467,871 |
| Gabapentin | Generic | 59 | 14 | $763 |
Hospital affiliations
Frequently asked questions
What is Dr. Tara Adhikari's medical specialty?
Dr. Tara Adhikari practices Rheumatology Physician in Blue Ash, OH.
Where does Dr. Tara Adhikari practice?
Dr. Tara Adhikari practices at 9403 Kenwood RD Ste C100, Blue Ash, OH 452426857. Office phone: 5139919990.
What is Dr. Tara Adhikari's NPI?
Dr. Tara Adhikari's National Provider Identifier (NPI) is 1508068594, issued by NPPES.
Does Dr. Tara Adhikari accept Medicare assignment?
Yes. Dr. Tara Adhikari accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Tara Adhikari commonly perform?
Top Medicare-reported procedures in 2023: Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS J0717); Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS J0129); Injection, golimumab, 1 mg, for intravenous use (HCPCS J1602). Source: CMS Medicare Physician & Other Practitioners file.